Overall, our results highlight the importance of these pathways in asthma, highlighting several common molecular elements (RELA, SMAD3, NFATC1, TLR2, and ALOX5) that were downregulated in AA and NA in the most severe phenotypes, opening possibilities in the search of new treatments useful for all asthmatic patients. The gene discussed is SMAD3; the disease is asthma.